Financhill
Sell
27

ARQ Quote, Financials, Valuation and Earnings

Last price:
$3.67
Seasonality move :
30.62%
Day range:
$3.62 - $3.81
52-week range:
$3.27 - $7.89
Dividend yield:
0%
P/E ratio:
165.00x
P/S ratio:
1.30x
P/B ratio:
0.72x
Volume:
250.1K
Avg. volume:
488.1K
1-year change:
-49.52%
Market cap:
$157.1M
Revenue:
$109M
EPS (TTM):
-$0.09

Earnings Data

Next earnings date for ARQ
Mar 04
2026
Most recent earnings per share
-$0.02
Missed by $0.04
(Nov 5/2025)
Consensus Estimate
$0.02
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ARQ Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/04/2026 Q4 $30M -- -- -$0.04 --
11/05/2025 Q3 $35.6M $35.1M -$0.02 $0.02 -$0.04
08/11/2025 Q2 $25.5M $28.6M -$0.05 -$0.03 -$0.02
05/07/2025 Q1 $26.3M $27.2M $0.00 -$0.02 $0.02
03/05/2025 Q4 $28.3M $27M -$0.03 -$0.02 -$0.01
11/07/2024 Q3 $30.4M $34.8M $0.04 $0.04 $0.01
08/12/2024 Q2 $20.6M $25.4M -$0.06 -$0.05 -$0.01
05/08/2024 Q1 $23.1M $21.7M -$0.09 -$0.07 -$0.02
03/12/2024 Q4 $27M $28.1M $0.10 -$0.08 $0.18
11/08/2023 Q3 -- $29.8M -$0.07 -- --
06/30/2023 Q2 -- $20.4M -$0.21 -- --
03/31/2023 Q1 -- $20.8M -$0.32 -- --
12/31/2022 Q4 -- $23.4M -$0.17 -- --
09/30/2022 Q3 -- $28.4M -$0.13 -- --
06/30/2022 Q2 -- $24.7M -$0.02 -- --
03/31/2022 Q1 -- $26.4M -$0.17 -- --
12/31/2021 Q4 -- $30.7M $0.31 -- --
09/30/2021 Q3 -- $30.9M $1.31 -- --
06/30/2021 Q2 -- $21.1M $0.90 -- --
03/31/2021 Q1 -- $22.6M $0.75 -- --
12/31/2020 Q4 -- $18.4M $0.02 -- --
09/30/2020 Q3 -- $19.5M $0.27 -- --
06/30/2020 Q2 -- $11.5M -$1.32 -- --
03/31/2020 Q1 -- $12.3M -$0.11 -- --
12/31/2019 Q4 -- $16M $0.50 -- --
09/30/2019 Q3 -- $19.1M $0.21 -- --
06/30/2019 Q2 -- $15.6M $0.44 -- --
03/31/2019 Q1 -- $19.3M $0.78 -- --
12/31/2018 Q4 -- $10.6M $0.36 -- --
09/30/2018 Q3 -- $5.1M $0.28 -- --
06/30/2018 Q2 -- $4.3M $0.75 -- --
03/31/2018 Q1 -- $3.9M $0.37 -- --
12/31/2017 Q4 -- $3.8M $0.32 -- --
09/30/2017 Q3 -- $5.1M $0.28 -- --
06/30/2017 Q2 -- $27.3M $0.29 -- --
03/31/2017 Q1 -- $9.1M $0.39 -- --
12/31/2016 Q4 -- $3.6M $3.40 -- --
09/30/2016 Q3 -- $15.7M $0.43 -- --
06/30/2016 Q2 -- $9M $0.35 -- --
03/31/2016 Q1 -- $22.4M $0.20 -- --
12/31/2015 Q4 -- $13.2M -$0.13 -- --

Arq, Inc. Earnings Questions

  • How Much did Arq, Inc. Generate in Revenue Last Quarter?

    Arq, Inc. reported $35.1M worth of top line sales in its most recent quarter.

  • Did Arq, Inc. Beat Earnings Last Quarter?

    Arq, Inc. announced earnings per share of -$0.02 which represents a miss of analyst forecast a $0.02 per share.

  • Is Arq, Inc. Profitable?

    Arq, Inc. reported $6.4M that represents $0.15 per share over the last quarter.

  • What is the Analyst Consensus for Arq, Inc. EPS Next Year?

    Arq, Inc.'s earnings are forecast to decrease from -$0.14 per share to -$0.13 per share next year representing a decrease of -22.37%.

  • When is Arq, Inc.'s Earnings Date?

    Arq, Inc.'s next earnings date is March 4, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock